Intracerebral Hemorrhage Clinical Trial
Official title:
Retrospective Study to Identify Correlations Between the Clinical Parameters, Analytics and Neuroimaging Data in Patients That Suffered of Intraparenchymal Cerebral Hemorrhage
NCT number | NCT04877405 |
Other study ID # | UHA-2021-1 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | May 10, 2021 |
Est. completion date | March 31, 2022 |
Verified date | May 2022 |
Source | Universitat Autonoma de Barcelona |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This is a retrospective observational study to investigate the clinical, analytical and neuroimaging data generated during routine clinical management of intracerebral hemorrhage. The study will review the data from about 500 patients attended during the last ten years in the Neurology Department of Hospital Parc Taulí de Sabadell. The aim is to measure the size of the lesion in neuroimage (TC and MRI), the edema, the alterations in diffusion weighted images and to correlate this data with clinical parameters and analytical measurements. With this approach investigators plan to investigate the incidence of hematoma growth, the role of perilesional edema and diffusion changes, and the relation between neuroimaging findings and clinical outcome. The study also try to establish significant correlations between clinical and analytical data, the clinical outcome and and the magnitude of changes in neuroimaging.
Status | Completed |
Enrollment | 137 |
Est. completion date | March 31, 2022 |
Est. primary completion date | March 31, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria: - Patients who have been attended at the Hospital Parc TaulĂ for the last 10 years after presenting an intraparenchymal hemorrhage. - The patients have had to undergo a computed tomography at the admission and a cranial magnetic resonance during the hospitalization in the time course specified in point in the protocol - The patients must present in their clinical story the analytical determinations detailed in the protocol. Exclusion Criteria: - Intracerebral hemorrhage secondary to head trauma - Intracerebral hemorrhage secondary to neoplasm |
Country | Name | City | State |
---|---|---|---|
Spain | Santiago Rojas Codina MD PhD | Cerdanyola del Valles | Barcelona |
Lead Sponsor | Collaborator |
---|---|
Universitat Autonoma de Barcelona | Hospital Parc Taulí, Sabadell |
Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Hematoma growth | Difference of hematoma size between CT conducted at admission and MRI conducted during follow up | 2 days | |
Primary | Correlation between hematoma growth and clinical paramenters | Determine the clinical parameters related with hematoma growth | 2 days | |
Primary | Correlation between hematoma growth and analytical parameters | Determine the analytical parameters related with hematoma growth | 2 days | |
Primary | Perilesional edema | Size of edema measured in FLAIR sequences | 2 days | |
Primary | Correlation between clinical parameters and the size of edema measured in FLAIR sequences | Determine the relationship between clinical parameters and the size of edema | 2 days | |
Primary | Correlation between analytical parameters and the size of edema measured in FLAIR sequences | Determine the relationship between analytical parameters and the size of edema | 2 days | |
Primary | Alterations in DWI | Size of alterations in diffusion weighted image | 2 days | |
Primary | Correlation between clinical parameters and the size of alterations in DWI | Determine the relationship between clinical parameters and the size of alterations in DWI | 2 days | |
Primary | Correlation between analytical parameters and the size of alterations in DWI | Determine the relationship between analytical parameters and the size of alterations in DWI | 2 days | |
Primary | Correlation between hematoma growth and clinical outcome | Determine the impact of hematoma growth on clinical outcome | 1 month | |
Primary | Correlation between perilesional edema size and clinical outcome | Determine the relationship between the size of edema and clinical outcome | 1 month | |
Primary | Correlation between the size of DWI alterations and clinical outcome | Determine the relationship between the size of DWI alterations and clinical outcome | 1 month | |
Primary | Correlation between the clinical parameters and clinical outcome | Determine the relationship between the clinical parametes and clinical outcome | 1 month | |
Primary | Correlation between the analyticial parameters and clinical outcome | Determine the relationship between the analytical parametes and clinical outcome | 1 month |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05089331 -
ROSE-Longitudinal Assessment With Neuroimaging
|
||
Recruiting |
NCT03605381 -
MORbidity PRevalence Estimate In StrokE
|
||
Active, not recruiting |
NCT04522102 -
Antiplatelet Secondary Prevention International Randomised Trial After INtracerebral haemorrhaGe (ASPIRING)-Pilot Phase
|
Phase 3 | |
Terminated |
NCT04178746 -
PRONTO: Artemis in the Removal of Intraventricular Hemorrhage in the Hyper-Acute Phase
|
||
Not yet recruiting |
NCT03956485 -
Multicentre Registry of Patients With Spontaneous Acute Intracerebral Hemorrhage in Catalonia (HIC-CAT).
|
||
Enrolling by invitation |
NCT02920645 -
Multicenter Validation of the AVICH Score
|
N/A | |
Recruiting |
NCT02625948 -
Tranexamic Acid for Acute ICH Growth prEdicted by Spot Sign
|
Phase 2 | |
Completed |
NCT02478177 -
Addressing Real-world Anticoagulant Management Issues in Stroke
|
||
Completed |
NCT01971359 -
Clinical Outcomes Following Parafascicular Surgical Evacuation of Intracerebral Hemorrhage: A Pilot Study
|
N/A | |
Completed |
NCT01261091 -
Early Tracheostomy in Ventilated Stroke Patients
|
N/A | |
Terminated |
NCT00990509 -
Albumin for Intracerebral Hemorrhage Intervention
|
Phase 2 | |
Completed |
NCT00716079 -
The Second Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial
|
N/A | |
Recruiting |
NCT00222625 -
rFVIIa in ICH in Patients Treated With Anticoagulants or Anti-Platelets
|
Phase 2 | |
Recruiting |
NCT05095857 -
The Anesthetic Ketamine as Treatment for Patients With Severe Acute Brain Injury
|
Phase 4 | |
Recruiting |
NCT04548596 -
NOninVasive Intracranial prEssure From Transcranial doppLer Ultrasound Development of a Comprehensive Database of Multimodality Monitoring Signals for Brain-Injured Patients
|
||
Not yet recruiting |
NCT06429332 -
International Care Bundle Evaluation in Cerebral Hemorrhage Research
|
Phase 4 | |
Recruiting |
NCT05492474 -
Cranial Ultrasound for Prehospital ICH Diagnosis
|
N/A | |
Not yet recruiting |
NCT05502874 -
Multicenter Registry for Assessment of Markers of Early Neurological Deterioration in Primary Intracerebral Hemorrhage
|
||
Recruiting |
NCT04604587 -
MRI-visible Enlarged Perivascular Spaces and the Alteration of Lymphatic Drainage System in CAA
|
Phase 3 | |
Recruiting |
NCT05504941 -
Detection of an Endovascular Treatment Target in Patients With an Acute, Spontaneous Intracerebral Hemorrhage
|
N/A |